(Q36262544)

13 August 2017

0 references

The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review (English)

1 reference

13 August 2017

0 references

1 reference

Jared Van Snellenberg

object named as

Jared X Van Snellenberg

2

0 references

Allen E. Thornton

object named as

Allen E Thornton

1

0 references

Amir A Sepehry

object named as

Amir A Sepehry

3

0 references

author name string

William Honer

4

1 reference

PubMed ID

16174678

13 August 2017

language of work or name

English

0 references

publication date

20 September 2005

1 reference

Journal of Psychopharmacology

13 August 2017

1 reference

13 August 2017

20

1 reference

13 August 2017

3

1 reference

13 August 2017

335-346

1 reference

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

13 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Medications and verbal memory impairment in schizophrenia: the role of anticholinergic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Clinical assessment of memory disorders in amnesia and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Another view of therapy for cognition in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Retrograde amnesia and remote memory impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

The effects of typical antipsychotics, clozapine, and risperidone on neuropsychological test performance in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Everyday memory and laboratory memory tests: general function predictors in schizophrenia and remitted depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Acetylcholine modulation of neural systems involved in learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

California Verbal Learning Test practice effects in a schizophrenia sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Risperidone versus haloperidol on secondary memory: can newer medications aid learning?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Association of anticholinergic load with impairment of complex attention and memory in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Clinical and neuropsychological correlates of the P300 in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Relationships between medication treatments and neuropsychological test performance in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

Does cognitive function improve with quetiapine in comparison to haloperidol?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881105057002

21 January 2018

Identifiers

DOI

10.1177/0269881105057002

1 reference

13 August 2017

1 reference

PubMed ID

16174678